Rampratap Kushwaha

Title: Rampratap Kushwaha: Innovator in Atherosclerosis Research

Introduction

Rampratap Kushwaha is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of biomedical research, particularly in the area of atherosclerosis. With a total of 2 patents, his work focuses on innovative solutions to combat this prevalent health issue.

Latest Patents

Kushwaha's latest patents include a CETP inhibitor polypeptide that targets cholesteryl ester transfer protein (CETP). This polypeptide and its analogues are designed to inhibit CETP, which plays a crucial role in lipid metabolism. His anti-atherosclerosis composition comprises an effective amount of the polypeptide combined with a pharmaceutically acceptable carrier. Additionally, he has developed an anti-atherosclerosis kit that includes the composition, a syringe, and a needle, all contained in separate sterile containers. His research also details methods for preventing and treating atherosclerosis in mammals, emphasizing the administration of therapeutically effective amounts of the polypeptide.

Career Highlights

Kushwaha is affiliated with the Southwest Foundation for Biomedical Research, where he continues to advance his research. His work has the potential to significantly impact the treatment and prevention of atherosclerosis, a condition that affects millions worldwide.

Collaborations

Some of his notable coworkers include Henry C McGill, Jr and Patrick Kanda, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Rampratap Kushwaha's innovative work in the field of atherosclerosis research showcases his dedication to improving health outcomes through scientific advancements. His patents reflect a commitment to developing effective treatments for this critical health issue.